Amylyx Ditches Controversial ALS Drug
Amylyx Pharmaceuticals has announced plans to take sodium phenylbutyrate–taurursodiol (Relyvrio and Albrioza), its drugs for amyotrophic lateral sclerosis (ALS), off ...
Read moreDetails
Tag: Amylyx
Amylyx May Pull FDA-Approved ALS Drug
Disappointing phase 3 trial results of a drug approved for the treatment of amyotrophic lateral sclerosis (ALS) may prompt the ...
Read moreDetails
The Earth News is an independent English-language daily published Website from all around the World News
